Setanaxib

Overview

Setanaxib (GKT137831) is a selective NADPH oxidase ( NOX1/4 ) inhibitor with K i s of 140 and 110 nM, respectively.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Coronavirus Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > NADPH Oxidase | Products > Signaling Pathways > Ferroptosis

Product Information

• Catalog No.: HY-12298
• CAS No.: 1218942-37-0
• Molecular Formula: C21H19ClN4O2
• Molecular Weight: 394.85
• Purity: 99.81%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: ≥ 2.08 mg/mL (5.27 mM); Clear solution
• Availability: In-stock

Source

Original product source